HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Willie, G. S. Search for Related Content PubMed Articles by Willie, G. S. Social Bookmarking                What's this?

The News on NCEP III

	STUDY

 
Executive summary of the third report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285:2486–2497, 2001[Free Full Text][Medline]

	SUMMARY

 
Background. The National Cholesterol Education Program (NCEP) has developed new guidelines for evaluating risk for cardiac disease. These new guidelines utilize the Framingham Point Score in determining risk assessment of new cardiac events within a 10-year period.

New Features. Previously, diabetes was considered to be one of several risk factors in the development of cardiac disease, including hypertension and family history of early cardiac disease. Based on new data, the Expert Panel has now recommended that the presence of diabetes be considered equivalent to the presence of established cardiac disease. The panel has also placed a new emphasis on identification of the metabolic syndrome and its management through early lifestyle modification interventions.

Conclusion. Diabetes is no longer considered to be a major risk factor, but rather is considered a cardiac disease equivalent. This should lead to more aggressive preventive measures among diabetic patients and, ultimately, to lower cardiovascular morbidity and mortality among these patients. The metabolic syndrome is now a secondary target of risk-reduction therapy.

	COMMENTARY

 
History of Diabetes and Cardiovascular Disease
Although the direct linkage between glycemic control and atherosclerotic disease has not been established, diabetes has long been associated with a marked increase in risk for coronary heart disease. Recent surveys have attributed 75% . . . [Full Text of this Article]

New Features of the NCEP III
Lipid and Lipoprotein Classification
Focus on Framingham
Risk Groups
Diabetes
Metabolic Syndrome
Summary of ATP III Goals

	Footnotes

 

	REFERENCES

 

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?